Fixed deductibles and low copays often mute patient price sensitivity for expensive care, making network design, utilization management, and value-based risk arrangements the main steering mechanisms.
In the final episode, Overcoming Barriers and Future Integration of Subcutaneous Therapies in Lung Cancer, the panelists ...
Myeloma delivery constraints are dominated by CAR T infrastructure and onboarding, while bispecifics are more ...
Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...
As reflected in its title, “Industry Payments to Cardiologists Are Associated With Higher Medicare Spending,” their ...
Continuous Medicare Advantage coverage was associated with higher last-year hospice enrollment (74.8%) and a ...
Glucocorticoid exposure was linked to higher incident toxicity rates, including ≥1 toxicity (61.9% vs 52.3%) and ≥3 ...
Repeated-measures modeling found no consistent links between active atopic dermatitis and BMI, blood pressure, lipid profiles ...
"The One Hundred Year Effect," a documentary about retired Oregon Health and Science Professor Kent Thornburg, PhD, and his ...
Subcutaneous amivantamab offers faster treatment, fewer infusion reactions, and improved convenience for patients with ...
Marked geographic variation in opioid prescribing persisted, exemplified by Alabama’s historically high rates and subsequent ...
Marked interindividual variability in organ size at comparable BMI supports organ dimensions as a potentially superior ...